HODGKIN'S DISEASE--PROGNOSIS, TREATMENT AND ETIOLOGIC AND IMMUNOLOGIC CONSIDERATIONS.
D000970:Antineoplastic Agents; D002699:Chlorambucil; D006689:Hodgkin Disease; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D009588:Nitrogen Mustard Compounds; D011379:Prognosis; D013514:Surgical Procedures, Operative; D014747:Vinblastine; D014750:Vincristine
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine
ANTINEOPLASTIC AGENTS; CHLORAMBUCIL; HODGKIN'S DISEASE; NEOPLASM RADIOTHERAPY; NITROGEN MUSTARD COMPOUNDS; PROGNOSIS; REVIEW; SURGERY, OPERATIVE; VINBLASTINE; VINCRISTINE